Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 5 out of 5 84.02

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Caps

How do you think GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,519 Outperform
90 Underperform
 

All-Star Players

716 Outperform
15 Underperform
 

Wall Street

29 Outperform
3 Underperform
 

Top GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

blakeman1000 (61.58)
Submitted February 17, 2017

This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.

nhatch3353 (47.57)
Submitted March 23, 2016

Patent problems and trouble with cancer drug trials.

GILD VS S&P 500 (SPY)

Fools bullish on GILD are also bullish on:

Fools bearish on GILD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

0
Member Avatar shanelofgren (31.35) Submitted: 1/5/2019 4:18:49 PM : Outperform Start Price: $68.10 GILD Score: -16.25

Bet on CAR-T. Prediction: they continue to acquire small and medium sized players who show strong results in novel indications (thinking MM to start, potentially AML down the line), and by doing so expand their franchise and leverage their manufacturing capabilities. Eventually they create the "must have product" in their respective indications, where efficacy is so much greater that comparable approaches that high treatment prices are tolerated. Eventually getting into earlier lines of treatment and
building a franchise that generates double digit CAGR cash streams that grow with their manufacturing capabilities and show little signs of competitive pressure (given troubles at Novartis and delays at BMS/Celgene/Juno) for years to come.

Certainly a bullish scenario. Threats come from delayed manufacturing growth, consistently high COGS, an inability to adjust and maintain market share / competitive position in the face of newer allogeneic approaches, toxicity limiting expansion to earlier line patients.

Additional threats center around the fact that most of Gilead's valuation is not in CAR-T, and thus that will be a sizable source of variance in this thesis. But, it's CAPS, so why not :)

Recs

0
Member Avatar TMFEBCapital (85.42) Submitted: 11/20/2018 11:14:15 AM : Outperform Start Price: $67.45 GILD Score: -9.88

NASH data and filgotinib data in 2019 could finally mark the long-awaited turning point for this company. It's HCV drag should wane next year, allowing HIV sales growth and potentially, new drug approvals, to return it to top line growth in 2020.

Recs

0
Member Avatar sojournerks (98.40) Submitted: 10/27/2018 10:25:15 AM : Outperform Start Price: $70.21 GILD Score: -12.43

Good company in a promising future sector

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (75.55) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
JSergeant 67.98 7/3/2006 Outperform 3Y $13.45 +383.31% +136.03% +247.27 0 Comment
UrineLuck73 < 20 1/29/2007 Outperform NS $14.21 +357.69% +110.75% +246.94 0 Comment
WilliamCrook2003 70.44 1/29/2007 1/25/2012 Outperform 5Y $14.21 +357.69% +110.75% +246.94 1 Comment
predragj 47.60 1/30/2007 Outperform NS $14.39 +351.90% +110.51% +241.39 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $14.45 +349.83% +109.79% +240.05 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $14.47 +349.21% +109.60% +239.61 0 Comment
opveiby 77.95 1/25/2007 Outperform 5Y $14.58 +345.84% +108.33% +237.51 0 Comment
Redskins2k9 < 20 1/25/2007 Outperform 5Y $14.58 +345.84% +108.33% +237.51 0 Comment
rmarinchek < 20 1/25/2007 Outperform 3W $14.58 +345.84% +108.33% +237.51 0 Comment
jer8899 67.51 1/23/2007 Outperform NS $14.55 +346.82% +109.63% +237.19 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.59 2/22/2017 Underperform 3W $64.83 +0.29% +19.49% +19.20 0 Comment
Anonymous331 35.92 2/3/2016 Outperform 5Y $78.18 -16.83% +47.50% -64.33 0 Comment
TrackJGreenblatt 53.44 8/18/2015 Outperform 1Y $106.42 -38.90% +34.28% -73.18 1 Comment
TrackJimCramer 85.59 2/23/2015 Outperform 3W $100.96 -31.82% +11.87% -43.69 2/22/2017 @ $68.83 0 Comment
TrackJimCramer 85.59 12/22/2014 Underperform 3W $92.90 +12.50% +1.80% -10.69 2/23/2015 @ $104.51 0 Comment
Anonymous331 35.92 3/6/2014 Underperform 5Y $81.98 -6.90% -1.08% +5.82 3/17/2014 @ $76.33 0 Comment
tracknomura 95.34 1/8/2014 Outperform NS $66.58 -2.34% +53.90% -56.24 0 Comment
TrackPiperJaff 85.55 11/27/2013 Outperform NS $67.77 -4.06% +56.10% -60.15 0 Comment
TrackArgus 86.79 6/14/2013 Outperform NS $47.22 +37.71% +72.12% -34.41 0 Comment
TrackCreditSuiss 89.08 3/26/2013 Underperform NS $41.08 +58.27% +81.46% +23.19 0 Comment
TrackZacks < 20 10/24/2012 Outperform 3M $34.17 +5.28% -1.76% +7.04 11/12/2012 @ $35.98 1 Comment
TrackLazardCapit 75.53 10/8/2012 Outperform NS $31.71 +105.04% +93.91% +11.13 0 Comment
TrackBernstein 88.12 10/1/2012 Outperform NS $31.00 +109.74% +95.36% +14.38 0 Comment
TrackBarclaysCap 87.65 8/3/2012 Outperform NS $26.33 +146.91% +103.76% +43.15 0 Comment
TrackJimCramer 85.59 7/27/2012 Outperform 3W $27.75 +234.77% +49.60% +185.17 12/22/2014 @ $92.90 0 Comment
TrackZacks < 20 2/21/2012 Underperform 3M $22.35 +16.72% +2.87% -13.84 4/27/2012 @ $26.08 1 Comment
TrackBarclaysCap 87.65 2/10/2012 Outperform NS $26.77 -15.15% +1.91% -17.06 2/21/2012 @ $22.71 0 Comment
TrackNeedham 90.39 2/3/2012 Outperform NS $24.30 +167.58% +110.69% +56.89 0 Comment
TrackJimCramer 85.59 11/29/2011 Underperform 3W $19.64 +41.33% +15.52% -25.81 7/27/2012 @ $27.75 0 Comment
TrackUltraLong < 20 11/23/2011 Underperform NS $19.76 +94.61% +24.35% -70.25 1/7/2013 @ $38.45 1 Comment
TrackGoldmanSach 81.59 10/21/2011 Outperform 5Y $18.83 +245.29% +129.37% +115.92 1 Comment
tracksummerstree 87.97 8/16/2011 Outperform NS $18.64 +2.36% -0.43% +2.79 11/22/2011 @ $19.07 0 Comment
TrackBreanMurray 62.09 8/9/2011 Outperform NS $16.96 +283.45% +147.51% +135.95 0 Comment
TrackJimCramer 85.59 3/25/2011 Outperform 3W $21.04 -6.68% -8.57% +1.89 11/30/2011 @ $19.64 0 Comment
TrackRBCCapMkts 87.22 11/1/2010 Outperform NS $18.16 +258.09% +137.11% +120.98 0 Comment
TrackZacks < 20 10/20/2010 Outperform 3M $19.20 -4.77% +6.38% -11.15 12/21/2010 @ $18.28 1 Comment
TrackMuhlenkamp 33.60 9/30/2010 Outperform NS $16.20 +301.33% +149.76% +151.57 0 Comment
Anonymous331 35.92 7/13/2010 Outperform NS $17.47 +17.60% +11.47% +6.13 10/19/2011 @ $20.55 0 Comment
TrackJimCramer 85.59 5/26/2010 Underperform 3W $17.41 +20.85% +22.52% +1.67 3/25/2011 @ $21.04 0 Comment
TrackPiperJaff 85.55 3/12/2010 Outperform NS $23.88 -12.08% +4.49% -16.57 4/21/2010 @ $20.99 0 Comment
TrackZacks < 20 3/1/2010 Outperform 3M $23.76 -2.44% +7.10% -9.54 4/13/2010 @ $23.18 1 Comment
TrackMorganJos 79.15 2/22/2010 Underperform NS $24.28 -25.52% -5.68% +19.84 5/25/2010 @ $18.08 0 Comment
TrackRothCapital 74.95 2/19/2010 Outperform NS $24.55 -16.21% +22.40% -38.61 5/3/2011 @ $20.57 0 Comment
TrackWedbush 87.65 10/21/2009 Underperform NS $20.60 +215.69% +158.92% -56.77 0 Comment
TrackMorganJos 79.15 4/22/2009 Outperform NS $23.12 +5.02% +31.77% -26.75 2/22/2010 @ $24.28 0 Comment
trackthinkequity 92.79 4/14/2009 Outperform NS $21.50 +202.46% +235.50% -33.03 0 Comment
TrackWedbush 87.65 3/13/2009 Outperform NS $22.30 +1.53% +44.09% -42.56 10/21/2009 @ $22.64 0 Comment
TrackStanfordRes < 20 12/23/2008 Outperform NS $25.07 -7.82% +57.74% -65.56 4/17/2012 @ $23.11 0 Comment
trackmerriman 68.44 12/15/2008 Outperform NS $20.45 +217.94% +225.39% -7.45 0 Comment
TrackNeedham 90.39 11/12/2008 Outperform NS $21.95 -2.89% +50.63% -53.52 3/31/2011 @ $21.32 0 Comment
TrackArgus 86.79 10/27/2008 Outperform NS $21.18 -9.28% +36.58% -45.86 11/23/2011 @ $19.21 0 Comment
TrackBofASec 92.42 10/24/2008 Outperform NS $19.48 +233.83% +244.04% -10.21 0 Comment
TrackZacks < 20 10/20/2008 Outperform 3M $23.25 +2.88% -4.74% +7.62 7/17/2009 @ $23.92 1 Comment
TrackBMOCapital < 20 10/17/2008 Outperform NS $19.52 +233.06% +208.84% +24.21 0 Comment
TrackRWBaird 87.40 9/12/2008 Outperform NS $22.48 +189.18% +134.33% +54.85 0 Comment
TrackLadenburg < 20 7/18/2008 Outperform NS $22.66 +186.92% +131.78% +55.14 0 Comment
TrackDeutscheSec 83.52 6/19/2008 Outperform NS $24.19 +168.79% +118.28% +50.50 0 Comment
TrackPacificGrow < 20 5/21/2008 Outperform NS $26.29 -12.10% -1.15% -10.95 4/17/2012 @ $23.11 0 Comment
TrackOppenheimer 68.51 4/17/2008 Outperform NS $23.20 +180.28% +114.99% +65.29 0 Comment
TrackJimCramer 85.59 4/2/2008 Outperform 3W $25.95 -32.91% -21.65% -11.26 5/26/2010 @ $17.41 0 Comment
TrackDodgeCox 93.74 3/31/2008 Outperform NS $23.44 +177.34% +121.85% +55.49 1 Comment
TrackJimCramer 85.59 3/13/2008 Underperform 3W $24.25 +7.03% +3.90% -3.13 4/3/2008 @ $25.95 0 Comment
TrackWellsFargo 88.35 1/31/2008 Outperform NS $20.42 +218.44% +120.57% +97.87 0 Comment
TrackFBRCapitalM 86.93 1/24/2008 Outperform NS $22.96 +15.31% -5.04% +20.35 6/30/2008 @ $26.48 0 Comment
TrackCreditSuiss 89.08 1/7/2008 Outperform NS $23.42 +92.53% +9.30% +83.23 3/25/2013 @ $45.08 0 Comment
TrackEdwardOwens 99.08 9/30/2007 Outperform NS $18.59 +249.68% +93.87% +155.81 7 Comments
TrackBMOCapital < 20 9/28/2007 Outperform NS $20.44 +25.73% -17.80% +43.53 7/18/2008 @ $25.70 0 Comment
TrackJimJubak < 20 9/25/2007 Outperform 1Y $20.36 +60.49% -8.55% +69.04 11/9/2012 @ $32.68 0 Comment
TrackZacks < 20 6/11/2007 Outperform 3M $19.81 +10.12% -9.23% +19.36 2/25/2008 @ $21.81 1 Comment
TrackJimCramer 85.59 5/18/2007 Outperform 3W $20.76 +16.82% -13.74% +30.56 3/14/2008 @ $24.25 0 Comment
TrackBWS 96.56 4/19/2007 Outperform NS $20.45 +14.19% -11.57% +25.76 1/18/2012 @ $23.36 0 Comment
TrackLeerinkSwan 97.77 4/19/2007 Outperform NS $17.97 +261.90% +103.61% +158.29 0 Comment
TrackJimCramer 85.59 4/5/2007 Underperform 3W $19.58 +6.00% +5.81% -0.19 5/19/2007 @ $20.76 0 Comment
TrackUBS 90.98 2/21/2007 Outperform NS $16.61 +291.55% +105.79% +185.76 0 Comment
TrackJefferies 80.67 2/21/2007 Outperform NS $18.25 +40.82% -13.96% +54.78 7/18/2008 @ $25.70 0 Comment
TrackDeutscheSec 83.52 2/2/2007 Outperform NS $17.75 +15.04% +5.60% +9.45 6/6/2007 @ $20.42 0 Comment
TrackPZK < 20 2/2/2007 Outperform NS $17.75 +30.17% -4.60% +34.77 4/17/2012 @ $23.11 0 Comment
TrackStifel 91.96 2/1/2007 Outperform NS $15.90 +308.91% +107.89% +201.01 0 Comment
TrackJMP 83.56 2/1/2007 Outperform NS $15.90 +308.91% +107.89% +201.01 0 Comment
TrackBofASec 92.42 2/1/2007 Outperform NS $17.46 +47.05% -9.91% +56.96 9/2/2008 @ $25.68 0 Comment
TrackCarisandCo 88.64 12/21/2006 Outperform NS $16.25 +49.25% -7.46% +56.71 3/13/2008 @ $24.25 0 Comment
TrackBroadpointAmTech < 20 12/19/2006 Outperform NS $15.93 +45.04% -2.37% +47.42 4/17/2012 @ $23.11 0 Comment
TrackRodmanRen < 20 12/4/2006 Outperform NS $14.97 +334.38% +113.66% +220.73 0 Comment
TrackLazardCapit 75.53 11/22/2006 Outperform NS $16.90 +70.53% -0.06% +70.59 8/7/2012 @ $28.82 0 Comment
TrackLehmanBros < 20 10/19/2006 Outperform NS $16.99 +55.41% -5.17% +60.58 8/28/2008 @ $26.41 0 Comment
TrackCreditSuiss 89.08 9/28/2006 Outperform NS $16.86 +21.10% +14.18% +6.91 6/6/2007 @ $20.42 0 Comment
TrackRBCCapMkts 87.22 9/27/2006 Outperform NS $16.72 -2.68% -18.97% +16.29 7/21/2010 @ $16.28 0 Comment
TrackMontgomery < 20 8/16/2006 Outperform NS $15.65 +9.86% -3.13% +12.99 10/1/2006 @ $17.19 0 Comment
TrackJimCramer 85.59 3/8/2006 Outperform 3W $15.20 +28.86% +12.72% +16.13 4/5/2007 @ $19.58 0 Comment

Advertisement